NAT-LANTHANUM

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 72d788b51ed95d81
Drug Approval Canada Name: NAT-LANTHANUM
Product Name: NAT-LANTHANUM
Status: Marketed
Status Date: 2020-07-21
Original Market Date: 2020-07-21
Din: 02498766
Drug Class: Human
Dosage Form: Tablet (Chewable)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 40:18.19
Atc Original: V03AE03 LANTHANUM CARBONATE
Atc Name: v 03 ae 03
Aig Number: 0151709003
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

LANTHANUM (LANTHANUM CARBONATE DIHYDRATE)

750 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

72d788b51ed95d81

Type

Standard